Coloma Jason V

Executive

US·SEC (Form 4)

Maze Therapeutics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 01 Oct 2026 for Maze Therapeutics, Inc., €823k. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

Coloma Jason V: trading record in brief

Coloma Jason V discloses dealings in Maze Therapeutics, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 1 July 2026 and the latest from 1 October 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 1 October 2026: a transaction of €823k, in Maze Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.